$2.19T
Total marketcap
$142.11B
Total volume
BTC 55.77%     ETH 8.89%
Dominance

Protagenic Therapeutics PTIXW Stock

$0.01   0.000000%
Add to favorites
Market Cap
$0.00
LOW - HIGH [24H]
$0.00 - $0.00
VOLUME [24H]
$0.00
P/E Ratio
0
Earnings per share
$0.00
ISIN
US74365N1110
Price   Prediction

Protagenic Therapeutics Price Chart

Sorry, that's all we've gotfor now...

Protagenic Therapeutics PTIXW Financial and Trading Overview

Protagenic Therapeutics stock price 0.02 USD
Previous Close 0 USD
Open 0.03 USD
Bid 0 USD x 0
Ask 0 USD x 0
Day's Range 0.02 - 0.02 USD
52 Week Range 0.02 - 0.02 USD
Volume 24.02K USD
Avg. Volume N/A
Market Cap N/A
Beta (5Y Monthly) N/A
PE Ratio (TTM) N/A
EPS (TTM) 0 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

PTIXW Valuation Measures

Enterprise Value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) N/A
Price/Book (mrq) N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Protagenic Therapeutics Stock Price History

Beta (5Y Monthly) N/A
52-Week Change N/A
S&P500 52-Week Change 29.59%
52 Week High 0.02 USD
52 Week Low 0.02 USD
50-Day Moving Average N/A
200-Day Moving Average N/A

PTIXW Share Statistics

Avg. Volume (3 month) N/A
Avg. Daily Volume (10-Days) N/A
Shares Outstanding N/A
Float N/A
Short Ratio N/A
% Held by Insiders N/A
% Held by Institutions N/A
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield NaN
5 Year Average Dividend Yield N/A
Payout Ratio N/A
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends N/A
Most Recent Quarter (mrq) N/A
Next Fiscal Year End N/A

Profitability

Profit Margin 0%
Operating Margin (ttm) 0%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) N/A
Return on Equity (ttm) N/A

Income Statement

Revenue (ttm) N/A
Revenue Per Share (ttm) N/A
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) N/A
EBITDA N/A
Net Income Avi to Common (ttm) N/A
Diluted EPS (ttm) N/A
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 2.21M USD
Total Cash Per Share (mrq) 1.22 USD
Total Debt (mrq) 4M USD
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) N/A
Book Value Per Share (mrq) -1.237

Cash Flow Statement

Operating Cash Flow (ttm) N/A
Levered Free Cash Flow (ttm) N/A

Profile of Protagenic Therapeutics

Country United States
State CA
City Santa Barbara
Address 701 Anacapa Street
ZIP 93101
Phone (805) 699-5596
Website https://phytanix.com
Industry
Sector(s)
Full Time Employees 1

Protagenic Therapeutics, Inc. operates as a pharmaceutical company specializing in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. Protagenic Therapeutics, Inc. was founded in 2004 and is based in Santa Barbara, California.

Q&A For Protagenic Therapeutics Stock

What is a current PTIXW stock price?

Protagenic Therapeutics PTIXW stock price today per share is 0.02 USD.

How to purchase Protagenic Therapeutics stock?

You can buy PTIXW shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Protagenic Therapeutics?

The stock symbol or ticker of Protagenic Therapeutics is PTIXW.

How many shares does Protagenic Therapeutics have in circulation?

The max supply of Protagenic Therapeutics shares is 0.

What is Protagenic Therapeutics Price to Earnings Ratio (PE Ratio)?

Protagenic Therapeutics PE Ratio is 0.00000000 now.

What was Protagenic Therapeutics earnings per share over the trailing 12 months (TTM)?

Protagenic Therapeutics EPS is 0 USD over the trailing 12 months.

Stocks Related By Sector

Stocks Related By Industry

Stocks Related By Marketcap

Select currency